Health ❯Healthcare ❯Medical Research ❯Clinical Trials

Cancer Treatment

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial

Frontline patients in the CADENZA trial saw a median overall survival of 16.6 months with peripheral edema as the primary manageable side effect.

Avelumab and Cetuximab Combo Quadruples Progression-Free Survival in Advanced cSCC

LUT014 Gel Shows Promise in Reducing Severe Rash from Colorectal Cancer Therapy

Zongertinib Achieves Breakthrough in Treating HER2-Mutant Lung Cancer

New Radioactive Therapy Shrinks Glioblastoma Tumor by Half in NHS Trial

Immunotherapy Shows Long-Term Success in Treating Metastatic Melanoma

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss